TOOKAD® Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

Purpose To evaluate the 6-month effects of the recommended drug and light dosage in focal vascular-targeted photodynamic therapy (VTP) using TOOKAD ® Soluble in patients with localized prostate cancer (LPCa). Methods We performed a pooled analysis of 117 men with LPCa, PSA

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of urology 2015-07, Vol.33 (7), p.945-953
Hauptverfasser:	Azzouzi, A. R., Barret, E., Bennet, J., Moore, C., Taneja, S., Muir, G., Villers, A., Coleman, J., Allen, C., Scherz, A., Emberton, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteriochlorophylls - therapeutic use Clinical Trials, Phase II as Topic Humans Male Medicine Medicine & Public Health Nephrology Oncology Photochemotherapy - methods Photosensitizing Agents - therapeutic use Prostatic Neoplasms - drug therapy Topic Paper Treatment Outcome Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose To evaluate the 6-month effects of the recommended drug and light dosage in focal vascular-targeted photodynamic therapy (VTP) using TOOKAD ® Soluble in patients with localized prostate cancer (LPCa). Methods We performed a pooled analysis of 117 men with LPCa, PSA
ISSN:	0724-4983 1433-8726 1433-8726
DOI:	10.1007/s00345-015-1505-8